Trials / Completed
CompletedNCT01356576
Effect of Hemodialysis Membranes on Platelet Count
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 99 (actual)
- Sponsor
- Northwell Health · Academic / Other
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine if there is a drop in platelet count after hemodialysis. Hemodialysis membranes are known to activate complement and cause a drop in platelets and sometimes in white blood cells. The investigators are going to study one of the membranes which is the Fresenius Optiflux® to check if it causes a drop in platelets.
Conditions
Timeline
- Start date
- 2010-09-01
- Primary completion
- 2011-09-01
- Completion
- 2011-09-01
- First posted
- 2011-05-19
- Last updated
- 2014-02-07
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01356576. Inclusion in this directory is not an endorsement.